Get 20% lifetime commission for referring investors to digrin.com
here.
Landos Biopharma, Inc. (LABP) Financials
Stock symbol LABP is outdated, potentially delisted? Maybe it is available on other exchange?
LABP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 43.2 million | 5.6 million |
| June 30, 2023 | 46.3 million | 3.0 million |
| March 31, 2023 | 51.2 million | 4.2 million |
| Dec. 31, 2022 | 45.3 million | 6.1 million |
LABP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -2.2 million | 248000 |
| June 30, 2023 | -5.1 million | 254000 |
| March 31, 2023 | -8.2 million | 224000 |
| Dec. 31, 2022 | -3.7 million | 196000 |
LABP Net Income
No data available :(
LABP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 42.5 million | - | - |
| June 30, 2023 | 44.7 million | - | - |
| March 31, 2023 | 50.0 million | - | - |
| Dec. 31, 2022 | 44.4 million | - | - |
LABP Shares Outstanding
LABP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 3.1 million | 2.1 million | - |
| June 30, 2023 | - | 2.5 million | 2.0 million | - |
| March 31, 2023 | - | 3.3 million | 3.2 million | - |
| Dec. 31, 2022 | 7000 | 3.4 million | 3.1 million | - |
LABP Cost of Revenue
No data available :(
LABP
Price: $22.93
52 week price:
Earnings Per Share: -3.50 USD
P/E Ratio: -1.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 125700
Market Capitalization: 69.4 million